Councilmark Asset Management’s AbbVie ABBV Stock Holding History

Councilmark Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.42M	Buy	11,137 +20	+0.2%	+$4.44K	1.39%	19
2025 Q4	$2.54M	Sell	11,117 -147	-1%	-$33.5K	1.42%	18
2025 Q3	$2.61M	Hold	11,264	–	–	1.5%	18
2025 Q2	$2.09M	Sell	11,264 -38	-0.3%	-$7.06K	1.32%	22
2025 Q1	$2.37M	Hold	11,302	–	–	1.6%	19
2024 Q4	$2.01M	Hold	11,302	–	–	1.35%	21
2024 Q3	$2.23M	Hold	11,302	–	–	1.5%	19
2024 Q2	$1.94M	Hold	11,302	–	–	1.37%	20
2024 Q1	$2.06M	Buy	+11,302	New	+$1.95M	1.48%	19

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Councilmark Asset Management's ABBV Position: Q1 2026 in Review

Councilmark Asset Management increased its AbbVie (ABBV) stake by 0.18% in Q1 2026, buying an estimated $4.44K and bringing the position to 11,137 shares worth $2.42M. The position accounts for 1.39% of the portfolio, ranked #19.

Councilmark Asset Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.61M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Councilmark Asset Management held 11,137 shares of AbbVie worth $2.42M as of Q1 2026.
Councilmark Asset Management bought 20 AbbVie shares in Q1 2026, an estimated $4.44K.
AbbVie made up 1.39% of Councilmark Asset Management's portfolio in Q1 2026, its #19 holding.
Councilmark Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
Councilmark Asset Management's AbbVie position peaked at $2.61M in Q3 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Councilmark Asset Management's 13F filing for Q1 2026, filed 12 May 2026.